Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -27.69 |
| peg ratio | 2.73 |
| price to book ratio | 16.21 |
| price to sales ratio | 5.76 |
| enterprise value multiple | -286.26 |
| price fair value | 16.21 |
profitability ratios | |
|---|---|
| gross profit margin | 88.67% |
| operating profit margin | 2.28% |
| pretax profit margin | -13.85% |
| net profit margin | -21.21% |
| return on assets | -13.31% |
| return on equity | -69.54% |
| return on capital employed | 1.79% |
liquidity ratio | |
|---|---|
| current ratio | 3.15 |
| quick ratio | 2.42 |
| cash ratio | 1.48 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 752.44 |
| operating cycle | 824.95 |
| days of payables outstanding | 87.95 |
| cash conversion cycle | 737.01 |
| receivables turnover | 5.03 |
| payables turnover | 4.15 |
| inventory turnover | 0.49 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.57 |
| debt equity ratio | 2.49 |
| long term debt to capitalization | 0.69 |
| total debt to capitalization | 0.71 |
| interest coverage | 0.22 |
| cash flow to debt ratio | -0.06 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.10 |
| cash per share | 0.82 |
| operating cash flow per share | -0.09 |
| free cash flow operating cash flow ratio | 1.19 |
| cash flow coverage ratios | -0.06 |
| short term coverage ratios | -3.10 |
| capital expenditure coverage ratio | -5.31 |
Frequently Asked Questions
Amicus Therapeutics, Inc. (FOLD) published its most recent earnings results on 06-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Amicus Therapeutics, Inc. (NASDAQ:FOLD)'s trailing twelve months ROE is -69.54%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Amicus Therapeutics, Inc. (FOLD) currently has a ROA of -13.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
FOLD reported a profit margin of -21.21% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.15 in the most recent quarter. The quick ratio stood at 2.42, with a Debt/Eq ratio of 2.49.